RT Journal Article
SR Electronic
T1 Susceptibility-adjusted herd immunity threshold model and potential <em>R</em><sub>0</sub> distribution fitting the observed Covid-19 data in Stockholm
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.19.20104596
DO 10.1101/2020.05.19.20104596
A1 P.V. Brennan
A1 L.P. Brennan
YR 2020
UL http://medrxiv.org/content/early/2020/05/22/2020.05.19.20104596.abstract
AB The reproduction number, R0, is commonly used, and sometimes misused, in conjunction with the classic Kermack and McKindrick theory based on the assumption of homogeneity, in order to estimate herd immunity threshold (HIT). This provides a crude first estimate of HIT, with more elaborate modelling required to arrive at a more realistic value. Early estimates of HIT for Covid-19 were based on this simplistic homogeneous approach, yielding high HIT values that have since been revised downwards with more sophisticated network modelling taking account of R0 heterogeneity and with reference to the low HIT found from serological sampling in Stockholm County. The aim of this paper is to describe a simple model in which host susceptibility is directly linked to the heterogeneous R0 distribution, to shed further light on the mechanisms involved and to arrive at a bimodal R0 distribution consistent with the Covid-19 HIT observed in Stockholm County.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialDue to time constraints and the need to present the work rapidly and make a valuable contribution to this area it has not been possible to obtain a trial ID.Funding StatementThe work is self-funded.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo specific detailed data has been used, but rather references to data from other articles.